Establishing prognostic models for intrahepatic cholangiocarcinoma based on immune cells

doi:10.4251/wjgo.v16.i10.4092

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (20)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-4)

Tables (1-3)

Sum=19

Oct 15, 2024 (publication date) through Sep 26, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Oct 15, 2024; 16(10): 4092-4103
Published online Oct 15, 2024. doi: 10.4251/wjgo.v16.i10.4092

Full Size Figure Download Figure

Figure 2 Establishing a 1-year Cox proportional hazards prognosis model for intrahepatic cholangiocarcinoma using stepwise selection and Cox multivariate regression. A: 1-year prognosis model nomogram established through multivariate COX regression using variables from stepwise selection of the 1-year prognostic model; B: Kaplan-Meier analysis of the 1-year prognosis model indicates a significant worsening in prognosis for high-risk vs low-risk individuals within 1 year (P < 0.001). AST: Aspartate aminotransferase.

Citation: Wang ZR, Zhang CZ, Ding Z, Li YZ, Yin JH, Li N. Establishing prognostic models for intrahepatic cholangiocarcinoma based on immune cells. World J Gastrointest Oncol 2024; 16(10): 4092-4103
URL: https://www.wjgnet.com/1948-5204/full/v16/i10/4092.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i10.4092